BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 24607815)

  • 1. Future initiatives to reduce lung cancer incidence in the United Kingdom: smoking cessation, radon remediation and the impact of social change.
    Denman AR; Rogers S; Timson K; Phillips PS; Crockett RG; Groves-Kirkby CJ
    Perspect Public Health; 2015 Mar; 135(2):92-101. PubMed ID: 24607815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung-cancer reduction from smoking cessation and radon remediation: a preliminary cost-analysis in Northamptonshire, UK.
    Groves-Kirkby CJ; Timson K; Shield G; Denman AR; Rogers S; Phillips PS
    Environ Int; 2011 Feb; 37(2):375-82. PubMed ID: 21109305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences motivating smokers in a radon-affected area to quit smoking.
    Groves-Kirkby CJ; Timson K; Shield G; Denman AR; Rogers S; Campbell J; Phillips PS; Ekberg M
    Perspect Public Health; 2014 Jan; 134(1):44-56. PubMed ID: 22843176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering the UK domestic radon Action Level to prevent more lung cancers--is it cost-effective?
    Denman AR; Coskeran T; Phillips PS; Crockett RG; Tornberg R; Groves-Kirkby CJ
    J Radiol Prot; 2008 Mar; 28(1):61-71. PubMed ID: 18309195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local health campaigns to reduce lung cancers induced by radon and smoking--who responds?
    Denman AR; Timson K; Shield G; Groves-Kirkby CJ; Rogers S; Campbell JA; Phillips PS
    Health Policy; 2009 Dec; 93(2-3):201-6. PubMed ID: 19712991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small area mapping of domestic radon, smoking prevalence and lung cancer incidence--A case study in Northamptonshire, UK.
    Denman AR; Rogers S; Ali A; Sinclair J; Phillips PS; Crockett RG; Groves-Kirkby CJ
    J Environ Radioact; 2015 Dec; 150():159-69. PubMed ID: 26334595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radon, smoking, and lung cancer: the need to refocus radon control policy.
    Lantz PM; Mendez D; Philbert MA
    Am J Public Health; 2013 Mar; 103(3):443-7. PubMed ID: 23327258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the health benefits and cost-effectiveness of the radon remediation programme in domestic properties in Northamptonshire, UK.
    Denman A; Groves-Kirkby C; Coskeran T; Parkinson S; Phillips P; Tornberg R
    Health Policy; 2005 Aug; 73(2):139-50. PubMed ID: 15978957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.
    Gray A; Read S; McGale P; Darby S
    BMJ; 2009 Jan; 338():a3110. PubMed ID: 19129153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom.
    Kennedy CA; Gray AM; Denman AR; Phillips PS
    Br J Cancer; 1999 Dec; 81(7):1243-7. PubMed ID: 10584889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of radon remediation programmes in the UK in the 2020s.
    Denman AR; Groves-Kirkby CJ; Crockett RGM
    J Environ Radioact; 2020 Oct; 222():106351. PubMed ID: 32892905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within primary care trusts in central England.
    Coskeran T; Denman A; Phillips P; Gillmore G; Tornberg R
    Sci Total Environ; 2006 Jul; 366(1):32-46. PubMed ID: 16574198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lung cancer in Iowa women: implications for prevention.
    Neuberger JS; Mahnken JD; Mayo MS; Field RW
    Cancer Detect Prev; 2006; 30(2):158-67. PubMed ID: 16581199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs and benefits of radon remediation programmes in existing homes: case study of action level selection.
    Denman AR; Phillips PS; Tornberg R
    J Environ Radioact; 2002; 62(1):17-27. PubMed ID: 12141604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radon-smoking synergy: A population-based behavioral risk reduction approach.
    Lee ME; Lichtenstein E; Andrews JA; Glasgow RE; Hampson SE
    Prev Med; 1999 Sep; 29(3):222-7. PubMed ID: 10479611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of lifetime lung cancer risks associated with radon exposure, based on various models and exposure scenarios.
    Hunter N; Muirhead CR; Bochicchio F; Haylock RG
    J Radiol Prot; 2015 Sep; 35(3):539-55. PubMed ID: 26083042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost effectiveness of radon reduction programmes in domestic housing in England and Wales: the impact of improved radon mapping and housing trends.
    Denman AR; Sinclair J; Phillips PS; Crockett RG; Groves-Kirkby CJ
    Environ Int; 2013 Sep; 59():73-85. PubMed ID: 23792416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness analysis of radon remediation programmes.
    Kennedy CA; Gray AM
    Sci Total Environ; 2001 May; 272(1-3):9-15. PubMed ID: 11379943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined analysis of North American case-control studies of residential radon and lung cancer.
    Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette use and the estimation of lung cancer attributable to radon in the United States.
    Lubin JH; Steindorf K
    Radiat Res; 1995 Jan; 141(1):79-85. PubMed ID: 7997518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.